Performance promotion
Company announcement
- VOLUNTARY ANNOUNCEMENT ANNOUNCEMENT OF PHASE III CLINICAL STUDY DATA OF BIREOCICLIB FOR FIRST-LINE TREATMENT OF HR+/HER2 - ADVANCED BREAST CANCER AT ESMO 2025
- ANNOUNCEMENT OF ALLOTMENT RESULTS
- List of Directors and their Role and Function
- Terms of Reference and Rules of Procedure of the Nomination Committee of the Board
- Terms of Reference and Rules of Procedure of the Remuneration and Appraisal Committee of the Board
- Terms of Reference and Rules of Procedure of the Audit Committee of the Board
- ARTICLES OF ASSOCIATION
- Documents on Display (Multi-Files)
- Documents on Display
- Documents on Display
9th Floor, North Tower of CP Center, No.20 Jin He East Avenue,Chaoyang District,Beijing,China
Tel：010-5765 4567
Email：XZGROUP@xuanzhubio.com
Copyright © 轩竹生物科技有限公司保留所有权利 冀ICP备2020028968号-2 网站建设技术支持：唯引互动
